AstraZeneca’s Trixeo has been approved in the EU as a [...]

Contactless monitoring of nocturnal cough has been linked to worsening [...]

AstraZeneca is evaluating its oral IRAK4 inhibitor AZD6793 in a [...]

Grifols has completed patient follow-up in its Phase 3 SPARTA [...]

Boehringer Ingelheim’s Jascayd has received European marketing authorisation for idiopathic [...]

AstraZeneca’s Trixeo Aerosphere has been recommended for approval in the [...]

EMBARC has announced its intention to collaborate with Insmed on [...]

Glasgow medical technology company Nebu~Flow has secured a £2 million [...]

The World Bronchiectasis Conference (WBC) will return to Hannover, Germany, [...]

GSK announced that the European Commission has approved Exdensur (depemokimab) [...]